Adroit Pharmaceuticals Pvt. Ltd. Rating Rationales / Reports

Title MID: 94622 30-Oct-2025 Issuer did not cooperate; Based on best available information; View Report MID: 83875 22-Nov-2024 Issuer did not cooperate; Based on best available information; View Report MID: 73986 07-Nov-2024 Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory; View Report MID: 73986 06-Nov-2023 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B; View Report MID: 67459 04-Nov-2022 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B +; View Report MID: 50671 09-Jul-2021 Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR BB -; Short Term Rating Reaffirmed; View Report MID: 40099 13-Apr-2020 Outstanding Ratings Reaffirmed; View Report MID: 38439 01-Apr-2020 Long Term Rating BWR BB/Stable Assigned; Short Term Rating BWR A4 Assigned; View Report